HER2 0, HER2 1+and HER2 2+/FISH Negative Primary Breast Cancers Are Biologically Distinct

被引：0
|
作者：
Donahue, Nolan [1 ]
Aragao, Alessa [2 ]
Gordezky, Rachel [3 ]
Haddad, Sandra [1 ]
Tang, Ping [1 ]
机构：
[1] Loyola Univ Med Ctr, Maywood, IL 60153 USA
[2] Mayo Clin, Rochester, MN USA
[3] Loyola Pathol, Chicago, IL USA
来源：
LABORATORY INVESTIGATION | 2024年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
122
引用
收藏
页码：S146 / S148
页数：3
相关论文
共 50 条
  • [41] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
    Wei, T.
    Wang, D.
    Peng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302
  • [42] Inconsistency of HER2 Status Between Core Needle Biopsy and Surgical Specimens: Focus on HER2 Null, HER2 Ultralow, and HER2 Low
    Wu, Si
    Liu, Hongbo
    Liu, Yueping
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [43] Correlation of HER2 gene and chromosome 17 status with pathologic factors in her2 2+ invasive breast cancer
    MacGrogan, G.
    Chibon, F.
    de Mascarel, I.
    Sierankowski, G.
    Brouste, V.
    MODERN PATHOLOGY, 2007, 20 : 40A - 40A
  • [44] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [45] Correlation of HER2 gene and chromosome 17 status with pathologic factors in her2 2+ invasive breast cancer
    MacGrogan, G.
    Chibon, F.
    de Mascarel, I.
    Sierankowski, G.
    Brouste, V.
    LABORATORY INVESTIGATION, 2007, 87 : 40A - 40A
  • [46] In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases
    Silvia Giuliani
    Chiara Maura Ciniselli
    Elena Leonardi
    Enzo Polla
    Nicola Decarli
    Claudio Luchini
    Chiara Cantaloni
    Fabio Gasperetti
    Daniela Cazzolli
    Gabriella Berlanda
    Daniela Bernardi
    Marco Pellegrini
    Renza Triolo
    Antonella Ferro
    Paolo Verderio
    Mattia Barbareschi
    Virchows Archiv, 2016, 469 : 45 - 50
  • [47] EGFR expression in ER negative and HER2 negative breast cancers
    Umemura, SM
    Takekoshi, S
    Osamura, RY
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2004, 52 : S39 - S39
  • [48] In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+and HER2 2+/Her2 amplified cases
    Giuliani, Silvia
    Ciniselli, Chiara Maura
    Leonardi, Elena
    Polla, Enzo
    Decarli, Nicola
    Luchini, Claudio
    Cantaloni, Chiara
    Gasperetti, Fabio
    Cazzolli, Daniela
    Berlanda, Gabriella
    Bernardi, Daniela
    Pellegrini, Marco
    Triolo, Renza
    Ferro, Antonella
    Verderio, Paolo
    Barbareschi, Mattia
    VIRCHOWS ARCHIV, 2016, 469 (01) : 45 - 50
  • [49] Genomic and clinical characterization of breast tumors with unusual HER2 FISH pattern (ratio < 2, HER2 copy number ≥ 6): Are they mostly HER2 "positive?"
    Wei, Christina H.
    Yang, Lixin
    Stewart, Daphne
    Bedell, Victoria
    Schmolze, Daniel
    Apple, Sophia
    Murata-Collins, Joyce L.
    Pillai, Raju
    Mortimer, Joanne E.
    CANCER RESEARCH, 2022, 82 (04)
  • [50] Are There More HER2 FISH in the Sea? An Institution's Experience in Identifying HER2 Positivity Using Fluorescent In Situ Hybridization in Patients with HER2 Negative Immunohistochemistry
    Suydam, Camille
    Chibane, Fairouz
    Brown, Nicole
    Schlafly, Madeleine
    Arnold, Alicia H.
    Ghleilib, Intisar
    Easley, Melissa
    White, Joseph
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : 376 - 381
12345